BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16919331)

  • 1. Constitutive CD40 signaling phenocopies the transforming function of the Epstein-Barr virus oncoprotein LMP1 in vitro.
    Hatzivassiliou EG; Kieff E; Mosialos G
    Leuk Res; 2007 Mar; 31(3):315-20. PubMed ID: 16919331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.
    Panagopoulos D; Victoratos P; Alexiou M; Kollias G; Mosialos G
    J Virol; 2004 Dec; 78(23):13253-61. PubMed ID: 15542676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.
    Eliopoulos AG; Dawson CW; Mosialos G; Floettmann JE; Rowe M; Armitage RJ; Dawson J; Zapata JM; Kerr DJ; Wakelam MJ; Reed JC; Kieff E; Young LS
    Oncogene; 1996 Nov; 13(10):2243-54. PubMed ID: 8950992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes.
    Busch LK; Bishop GA
    J Immunol; 1999 Mar; 162(5):2555-61. PubMed ID: 10072495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.
    Middeldorp JM; Pegtel DM
    Semin Cancer Biol; 2008 Dec; 18(6):388-96. PubMed ID: 19013244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth.
    Baxendale AJ; Dawson CW; Stewart SE; Mudaliar V; Reynolds G; Gordon J; Murray PG; Young LS; Eliopoulos AG
    Oncogene; 2005 Nov; 24(53):7913-23. PubMed ID: 16091748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.
    Gires O; Zimber-Strobl U; Gonnella R; Ueffing M; Marschall G; Zeidler R; Pich D; Hammerschmidt W
    EMBO J; 1997 Oct; 16(20):6131-40. PubMed ID: 9359753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by rewiring the signal transduction of Epstein-Barr virus oncoprotein LMP1 toward caspase activation.
    Hatzivassiliou EG; Tsichritzis T; Mosialos G
    J Virol; 2005 Apr; 79(8):5215-9. PubMed ID: 15795305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LMP1 strain variants: biological and molecular properties.
    Mainou BA; Raab-Traub N
    J Virol; 2006 Jul; 80(13):6458-68. PubMed ID: 16775333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.
    Kieser A
    Biol Chem; 2008 Oct; 389(10):1261-71. PubMed ID: 18713013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments.
    Lam N; Sugden B
    EMBO J; 2003 Jun; 22(12):3027-38. PubMed ID: 12805217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology.
    Yan G; Li L; Tao Y; Liu S; Liu Y; Luo W; Wu Y; Tang M; Dong Z; Cao Y
    Proteomics; 2006 Mar; 6(6):1810-21. PubMed ID: 16470631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
    Zheng H; Li LL; Hu DS; Deng XY; Cao Y
    Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.
    Graham JP; Arcipowski KM; Bishop GA
    Immunol Rev; 2010 Sep; 237(1):226-48. PubMed ID: 20727039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40.
    Buettner M; Meyer B; Schreck S; Niedobitek G
    Int J Cancer; 2007 Dec; 121(12):2703-10. PubMed ID: 17721998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenicity of mouse BALB/c 3T3 fibroblast cells which express Epstein-Barr virus-encoded LMP1 and show normal growth phenotypes in vitro is correlated with loss of transforming growth factor-beta 1-mediated growth inhibition.
    Takanashi M; Li J; Shirakata M; Mori S; Hirai K
    Arch Virol; 1999; 144(2):241-57. PubMed ID: 10470251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of the CD40-related immunodeficient response in hyper-IgM B cells immortalized with a LMP1-regulated mini-EBV.
    Lu KT; Dryer RL; Song C; Covey LR
    J Leukoc Biol; 2005 Sep; 78(3):620-9. PubMed ID: 15961576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
    Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.
    Zimber-Strobl U; Kempkes B; Marschall G; Zeidler R; Van Kooten C; Banchereau J; Bornkamm GW; Hammerschmidt W
    EMBO J; 1996 Dec; 15(24):7070-8. PubMed ID: 9003782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling.
    Tsai CL; Li HP; Lu YJ; Hsueh C; Liang Y; Chen CL; Tsao SW; Tse KP; Yu JS; Chang YS
    Cancer Res; 2006 Dec; 66(24):11668-76. PubMed ID: 17178861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.